PetVivo raises $1.42M gross via registered direct offering of 610,011 shares at $2.32/share

PetVivo Holdings, Inc.

610,011 shares sold at $2.32/share; gross proceeds $1,415,225.52.
Net proceeds ~$1.39M after $25k expenses; closings on Jan 9 and Jan 13, 2023.
Proceeds for commercialization of Spryng™ with OsteoCushion™ Tech, clinical trials, working capital.
Offering directly to accredited investors; no placement agent.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

PetVivo Holdings, Inc. amended Amended Purchase Agreement with certain accredited investors valued at $1,415,225.52 (effective 2023-01-05).

Action: amendment
Agreement: equity purchase
Counterparty: certain accredited investors
Value: $1,415,225.52
Effective: 2023-01-05

Exact text from the filing

On January 5, 2023, PetVivo Holdings, Inc. (the “Company”) entered into an amended and restated securities purchase agreement with certain accredited investors (the “Amended Purchase Agreement”), pursuant to which the Company agreed to issue and sell an aggregate of 610,011 Registered Shares in the Registered Offering at a purchase price of $2.32 per share.

View on SEC.gov

Browse all material agreements →

PetVivo Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-001941

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.